regu 33 of sebi lodr 2015

Revenue declinedProfit growth above 25%Negative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹23.24

prior close

₹24.24

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-1.8% vs market

Pharmaceuticals peers, median of 150sector+0.2%-1.1% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-2.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.8-1.8+0.2-1.1

Next day

-3.9+2.0-5.9+1.1-5.1

+2.8+0.9+1.9+0.1+2.7

-1.2+1.7-2.8+1.0-2.2

-3.1+1.6-4.7+1.2-4.3

+1.1+2.2-1.1+0.7+0.4

+1.1+2.7-1.6+1.4-0.3

15d

+4.3+4.5-0.2+0.6+3.7

+3.3+5.6-2.3+2.1+1.2

+21.3+9.0+12.4+3.8+17.5

+6.2+3.5+2.6-1.0+7.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unjha Formulations Ltd reported audited FY25 results with total operating income of ₹1,397.68 lacs, down about 24.5% from ₹1,850.75 lacs in FY24, mainly due to lower cost of materials consumed. Despite the revenue decline, FY25 profit after tax rose to ₹40.76 lacs from ₹27.79 lacs in FY24, a jump of roughly 47%, translating to EPS of ₹0.91 vs ₹0.62. Q4 FY25, however, was weak with a net loss of ₹40.64 lacs versus a ₹17.50 lacs loss in Q4 FY24. The balance sheet shows other equity in the negative at ₹(134.17) lacs, indicating accumulated losses, while cash and equivalents fell to ₹64.38 lacs from ₹87.47 lacs. Net cash from operating activities turned negative at ₹(4.49) lacs compared to ₹102.61 lacs last year. The statutory auditor (Jain & Golechha) issued an un-modified opinion, and the board also appointed M/s Ajay Parikh & Associates as Secretarial Auditor for FY26–FY30.

Likely market impact

The un-modified audit opinion is reassuring, but shrinking revenue, a negative other equity, and negative operating cash flow signal stress in operations. Full-year PAT growth is largely a cost-side story rather than demand recovery, so investors should watch Q1 FY26 for signs of revenue stabilisation before turning constructive.